Q-linea AB

Equities

QLINEA

SE0011527845

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm Other stock markets 16:29:36 24/05/2024 BST			5-day change	1st Jan Change
2.36 ^SEK	+4.19%		+7.27%	-36.22%

04-26	Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System	CI
03-13	Q-linea AB Presents Strong ASTar Results At AMCLI	CI

Q-linea AB Announces Marcus Storch Not Available for Re-Election as Member of Board of Directors

April 25, 2022 at 01:00 pm

Q-linea AB (publ) at its annual general meeting to be held on May 24, 2022, announced that Marcus Storch has informed the Nomination Committee that he is not available for re-election as member of the board of directors.

Latest news about Q-linea AB

Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System	04-26	CI
Q-linea AB Presents Strong ASTar Results At AMCLI	03-13	CI
Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024	02-27
Q-linea AB Reports Earnings Results for the Full Year Ended December 31, 2023	02-27	CI
Q-linea AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	02-27	CI
Q-linea Presents at AMCLI	02-15	CI
Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary	02-09	MT
Q-Linea AB Appoints Anders Ljunggren as Managing Director, Effective 1 March 2024	02-01	CI
Q-linea Lands First ASTar Order from Finnish Distributor	01-31	MT
Q-Linea AB Receives an Order for an ASTar System	01-31	CI
Q-linea to Cut 40 Jobs in Cost Savings Program	01-30	MT
Q-linea AB Announces CEO Changes	01-22	CI
Q-linea AB Expands the Gram-Negative Panel	01-17	CI
Q-Linea Wins Public Tender for Rapid AST	01-15	CI
Q-linea Installs First ASTar Systems in US; Shares Jump	12-28	MT
Q-linea Signs Distribution Deal for Benelux Region with Biomedical Diagnostics	11-17	MT
Transcript : Q-linea AB, Q3 2023 Earnings Call, Nov 02, 2023	11-02
Q-linea AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-02	CI
Sweden's Q-linea Partners with Labema to Boost Presence in Finland, Baltic States	19/10/23	MT
Q-Linea AB Strengthens its Presence in Finland and the Baltics Through Partnership with Labema Oy	19/10/23	CI
Q-linea AB Receives Second ASTar Order in France	28/09/23	CI
Q-linea CEO Plans Retirement in 2024; Stock Tumbles 13%	07/09/23	MT
Q-Linea AB Announces Jonas Jarvius to Step Down as CEO Before Summer 2024	07/09/23	CI
Q-Linea AB Appoints Jonas Jarvius as A New Board Member in 2024	07/09/23	CI
Q-linea Shares Gain Amid Progress of French Distribution Deal	27/07/23	MT

Chart Q-linea AB

Duration

Period

More charts

Company Profile

Q linea AB is a Sweden-based medical technology company. The Company develops and manufactures in-vitro diagnostic (IVD) solutions for infectious diseases. The Company's core product candidate is ASTar, a fully-automated instrument for Antibiotic Susceptibility Testing (AST). It measures bacteria's antimicrobial susceptibility using the disposables developed by the Company. It is able to provide a susceptibility profile within three to six hours directly from a positive blood culture, which enables early administration of antibiotics specifically targeting the disease-causing pathogen. Its main application is the identification of sepsis in hospital patients and the product is aimed primarily at hospital laboratories.

Sector

Advanced Medical Equipment & Technology

Calendar

28/05/2024 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Q-linea AB

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
Q-LINEA AB	-36.22%	24.64M
SARTORIUS AG	-24.07%	17.58B
QUIDELORTHO CORPORATION	-42.47%	2.8B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+13.40%	1.88B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-10.21%	1.55B
BIOTAGE AB	+32.69%	1.34B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-21.01%	936M
CONTEC MEDICAL SYSTEMS CO.,LTD	-25.79%	859M
REVENIO GROUP OYJ	+5.15%	818M
VAREX IMAGING CORPORATION	-27.85%	600M

Medical Diagnostic & Testing Equipment